Skip to content

The Frisian Trauma and Personality Studies: Two-year course of personality disorders and trauma-related disorders in patients in mental health care

The Frisian Trauma and Personality Studies: Two-year course of personality disorders and trauma-related disorders in patients in mental health care - The Frisian Trauma and Personality Studies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40511
Enrollment
200
Registered
2014-02-18
Start date
2014-05-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatized

Interventions

None listed

Sponsors

GGZ Friesland (Leeuwarden)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must have participated in the SECT-study (baseline study). See page 18 of the research protocol.

Exclusion criteria

Exclusion criteria: patients who speak Dutch insufficiently

Design outcomes

Primary

MeasureTime frame
What is the course of (symptoms of) trauma-related and personality disorders in a sample of patients in treatment over a follow-up period of two years? More specifically, what is the course of the core symptoms (PTSD, dissociation, personality pathology, affect regulation and general functioning) in a sample of treatment seeking adults?

Secondary

MeasureTime frame
Is it possible to relate the diagnostic square to changeability of psychopathology within a period of two year? What are demographic (gender, age) and clinical (dissociation, comorbidity in general, personality pathology) predictors of a favourable course after two years? To what extent is course outcome dependent on the type or duration of treatment (e.g., inpatient, outpatient, crisis, and pharmacotherapy, psychotherapy or supportive therapy)?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)